EPFL Laboratory of Lymphatic and Cancer Bioengineering (LLCB)

Switzerland

1 December 2019 - 30 November 2020

No articles found. EPFL Laboratory of Lymphatic and Cancer Bioengineering (LLCB) did not contribute to any primary research papers from Nature Index journals in the current 12 month window.

EPFL Interfaculty Institute of Bioengineering (IBI)

↳ EPFL Laboratory of Lymphatic and Cancer Bioengineering (LLCB)

EPFL BioNanoPhotonic Systems Laboratory (BIOS)

EPFL Biorobotics Laboratory (BioRob)

EPFL Laboratory for Bio- and Nano-Instrumentation (LBNI)

EPFL Laboratory for Biomolecular Modeling (LBM)

EPFL Laboratory for Fundamental BioPhotonics (LBP)

EPFL Laboratory of Integrative and Systems Physiology (LISP)

EPFL Laboratory of Metabolic Signaling

EPFL Laboratory of Nanoscale Biology (LBEN)

EPFL Laboratory of Stem Cell Bioengineering (LSCB)

EPFL Laboratory of Systems Biology and Genetics (LSBG)

Return to institution outputs

Latest supplement

Nature Index 2020 Artificial Intelligence

Artificial intelligence is one of the most rapidly advancing and controversial topics in scientific research. As investments and revenues soar year-on-year and nations vie for leadership in the field, AI research output continues its steep, upward trajectory. But there are significant ethical and technical challenges to overcome.

Access free

Research highlights of partners

Research highlights

Sign up for the free weekly Nature Index newsletter
Sign up

Useful links